COVID-19 Vaccines

COVID-19 Vaccines

Information on the COVID-19 vaccine is evolving and current evidence is limited. Ensure to follow local public health measures. In order to make data available for Canadians, people living in the United States, and the rest of the world, we included information from the Public Health Agency of Canada, Centers for Disease Control and Prevention, and the World Health Organization.

Public Health Agency of Canada (PHAC)
  • Vaccines that are authorized for use in Canada include:
    • Pfizer-BioNTech COVID-19 vaccine for individuals 16 years of age and older
    • Moderna COVID-19 vaccine for individuals 18 years of age and older
    • AstraZeneca COVID-19 vaccine for individuals 18 years of age and older
  • According to current clinical trials, no serious safety concerns related to the vaccines have been identified, however studies are ongoing
  • COVID-19 vaccines are currently prioritized to individuals according to the National Advisory Committee on Immunization (NACI) Guidance on the Prioritization of Initial Doses of COVID-19 Vaccine(s)
  • NACI currently recommends that COVID-19 vaccines should not be offered to individuals who are not in the authorized age group
  • Regardless of vaccination with COVID-19 vaccine, all individuals should continue to practice recommended public health measures (e.g., good handwashing and physical distancing)

Read more here: 

Public Health Agency of Canada. COVID-19: Recommendations on the use of COVID-19 vaccines.https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html#a7

Centers for Disease Control and Prevention (CDC)
  • Vaccines that have been authorized and recommended to prevent COVID-19 are:
    • ​​​​Pfizer-BioNTech COVID-19 vaccine
    • Moderna’s COVID-19 vaccine
    • Johnson & Johnson’s Janssen COVID-19 Vaccine
  • According to the Advisory Committee on Immunization Practices (ACIP), the initial phase of the COVID-19 vaccination program will include healthcare personnel and individuals in long-term care facilities. Subsequent phases of the COVID-19 vaccination program include Phase 1b (frontline essential workers and individuals 75 years of age and older) and Phase 1c (other essential workers, persons 65–74 years of age, and individuals 16–64 years of age with underlying medical conditions).
  • The CDC is currently conducting two studies on COVID-19 vaccines in children. The first study is researching children’s immune responses against COVID-19 vaccines, and it is studying the immune response in children previously infected with COVID-19 (1). The objective of the second study is to research children who are at high risk for severe COVID-19 outcomes (2).

Read more here:

Centers for Disease Control and Prevention. Vaccination Implementation Strategies to Consider for Populations to Receive Initial Doses of COVID-19 Vaccine. https://www.cdc.gov/vaccines/covid-19/implementation-strategies.html

Centers for Disease Control and Prevention. US Influenza Vaccine Effectiveness Network Protocol for

Influenza and Other Respiratory Viruses (including COVID-19). https://www.cdc.gov/vaccines/covid-19/downloads/us-flu-vaccine-effectiveness-network-protocol.pdf 

Centers for Disease Control and Prevention. Virtual Network: Investigating the Risk of Influenza-Associated

Outcomes and Influenza Vaccine Effectiveness Using Integrated

Medical and Public Health Records (VISION) with COVID-19related addendum. https://www.cdc.gov/vaccines/covid-19/downloads/vision-cohort-protocol-508.pdf

World Health Organization (WHO)
  • COVID-19 vaccines are beginning to be introduced in countries
  • The World Health Organization is currently working with global partners to accelerate vaccine approval and distribution processes while making sure that safety standards are met
  • Vaccinations should be prioritized for health workers at risk of high exposure, followed by older adults, then the rest of the population
  • Vaccines approved for emergency use by WHO include:
    • Pfizer-BioNTech COVID-19 vaccine 
    • AstraZeneca/Oxford COVID-19 vaccine
  • At this time, the WHO does not recommend vaccination of children below 16 years of age, even if they belong to a high-risk group, for the Pfizer-BioNTech COVID-19 vaccine
  • The AstraZeneca/Oxford COVID-19 vaccine is not recommended for individuals under 18 years of age
  • A study is underway evaluating RNA COVID-19 vaccination candidates which includes children between 12 and 15 years of age
  • It is recommended to continue practicing public health measures (e.g., physical distancing and wearing masks)

Read more here: 

World Health Organization. Who can take the Pfizer-BioNTech COVID-19 vaccine? https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19–vaccine

Here is a preview of our most recent updates on the vaccine development:

References

  1. Public Health Agency of Canada. COVID-19: Recommendations on the use of COVID-19 vaccines. https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines.html#a7
  2. Centers for Disease Control and Prevention. Vaccination Implementation Strategies to Consider for Populations to Receive Initial Doses of COVID-19 Vaccine. https://www.cdc.gov/vaccines/covid-19/implementation-strategies.html
  3. Centers for Disease Control and Prevention. US Influenza Vaccine Effectiveness Network Protocol forInfluenza and Other Respiratory Viruses (including COVID-19). https://www.cdc.gov/vaccines/covid-19/downloads/us-flu-vaccine-effectiveness-network-protocol.pdf
  4. Centers for Disease Control and Prevention. Virtual Network: Investigating the Risk of Influenza-Associated. Outcomes and Influenza Vaccine Effectiveness Using Integrated Medical and Public Health Records (VISION) with COVID-19related addendum. https://www.cdc.gov/vaccines/covid-19/downloads/vision-cohort-protocol-508.pdf
  5. World Health Organization. Who can take the Pfizer-BioNTech COVID-19 vaccine? https://www.who.int/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19–vaccine

Disclaimer: The information regarding COVID-19 is changing constantly as more data become available. The information provided in this website is not meant to replace diabetes healthcare team or public health agencies recommendations, and is intended for information purposes only. Please check with your healthcare providers for any deviations from your care plans.


Our Partnerships